Gentamicin sulfate, 100X solution [1405-41-0]

Gentamicin sulfate is a powerful broad-spectrum antibiotic that exhibits minimal toxicity to viruses and mammalian cells even at antibacterial concentrations. It effectively inhibits the growth of both gram-positive and gram-negative bacteria, as well as mycoplasma. This antibiotic exerts its action by binding to the L6 protein of the 50S ribosomal subunit, thereby impeding normal protein synthesis. Notably, it is particularly valuable in Baculovirus expression systems due to its ability to overcome mutations in rplF that render other antibiotics ineffective. Comprised of various gentamicin components, gentamicin sulfate is classified as an aminoglycoside antibiotic. The primary constituents, namely gentamicin C1, gentamicin C1a, and gentamicin C2, make up approximately 80% of gentamicin and exhibit the highest antibacterial potency. The remaining 20% is comprised of gentamicin A, B, X, and a few others, which possess comparatively lower antibiotic activity when compared to the gentamicin C complex. Gentamicin displays a slight solubility in aqueous solutions, with a concentration of approximately 12.6 mg/mL.

References:

1. Investigation of the in vitro release of gentamicin from a polyanhydride matrix.  |  Stephens, D., et al. 2000. J Control Release. 63: 305-17. PMID: 10601726
2. Elution of metronidazole and gentamicin from polymethylmethacrylate beads.  |  Ramos, JR., et al. 2003. Vet Surg. 32: 251-61. PMID: 12784202
3. A controlled and sustained local gentamicin delivery system for inner ear applications.  |  Xu, L., et al. 2010. Otol Neurotol. 31: 1115-21. PMID: 20616758
4. A new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis.  |  Su, WY., et al. 2013. Evid Based Complement Alternat Med. 2013: 801374. PMID: 23662153
5. Intratympanic gentamicin as a treatment for drop attacks in patients with Meniere′s disease.  |  Viana, LM., et al. 2014. Laryngoscope. 124: 2151-4. PMID: 24729095
6. Electrophoretic deposition of gentamicin-loaded bioactive glass/chitosan composite coatings for orthopaedic implants.  |  Pishbin, F., et al. 2014. ACS Appl Mater Interfaces. 6: 8796-806. PMID: 24827466
7. Chemical injury of the spinal cord of the rabbit after intracisternal injection of gentamicin.  |  Watanabe, I., et al. 1979. J Neuropathol Exp Neurol. 38: 104-13. PMID: 261984
8. Sensory hair fusion and glycocalyx changes after gentamicin exposure in the guinea pig.  |  Takumida, M., et al. 1989. Acta Otolaryngol Suppl. 457: 78-82. PMID: 2929338
9. Collagen-shield delivery of gentamicin and vancomycin.  |  Phinney, RB., et al. 1988. Arch Ophthalmol. 106: 1599-604. PMID: 3190546
10. An IgG, gentamicin sulfate-dependent antibody found during prenatal antibody screening.  |  Peloquin, PM., et al. 1986. Vox Sang. 51: 321-3. PMID: 3798866
11. A clinical comparison of tobramycin and gentamicin sulfate in the treatment of ocular infections.  |  Laibson, P., et al. 1981. Am J Ophthalmol. 92: 836-41. PMID: 7032304
12. Damage and recovery of hair cells in fish canal (but not superficial) neuromasts after gentamicin exposure.  |  Song, J., et al. 1995. Hear Res. 91: 63-71. PMID: 8647725
13. Stability of gentamicin sulfate injection following unit dose repackaging.  |  Weiner, B., et al. 1976. Am J Hosp Pharm. 33: 1254-9. PMID: 998642